CHLORPHENIRAMINE MALEATE tablet United States - English - NLM (National Library of Medicine)

chlorpheniramine maleate tablet

bryant ranch prepack - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - chlorpheniramine maleate 4 mg

CHLORPHENIRAMINE MALEATE 4 MG tablet United States - English - NLM (National Library of Medicine)

chlorpheniramine maleate 4 mg tablet

remedyrepack inc. - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - chlorpheniramine maleate 4 mg

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE solution United States - English - NLM (National Library of Medicine)

hydrocodone bitartrate and chlorpheniramine maleate solution

acella pharmaceuticals, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate and chlorpheniramine maleate oral solution is indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older. important limitations of use not indicated for pediatric patients under 18 years of age [see use in specific populations ( 8.4)] . hydrocodone bitartrate and chlorpheniramine maleate oral solution is contraindicated in: - patients with known hypersensitivity to hydrocodone bitartrate, chlorpheniramine maleate or any of the inactive ingredients of hydrocodone bitartrate and chlorpheniramine maleate oral solution. - patients receiving maoi therapy or within 14 days of stopping such therapy. - patients with narrow angle glaucoma, urinary retention, severe hypertension, or severe coronary artery disease. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies of hydrocodone bitartrate and chlorpheniramine maleate oral solut

BRONKOF SYRUP Kenya - English - Pharmacy and Poisons Board

bronkof syrup

laboratory & allied ltd p.o box 42875-00100 nairobi - chlorpheniramine maleate,codeine phosphate and… - syrup - chlorpheniramine maleate 2mg,codeine phosphate… - cough suppressants and expectorants combinations:

STONARHINI- chlorpheniramine maleate, phenylephrine tablet United States - English - NLM (National Library of Medicine)

stonarhini- chlorpheniramine maleate, phenylephrine tablet

sato pharmaceutical co., ltd. - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - chlorpheniramine maleate 2 mg - purpose chlorpheniramine maleate    antihistamine phenylephrine hcl        nasal decongestant uses temporarily relieves these symptoms due to common cold, hay fever or other upper respiratory allergies (allergic rhinitis). ■ sneezing        ■ runny nose    ■ itchy, watery eyes ■ nasal congestion, stuffy nose        ■ itchy throat

TUZISTRA XR- codeine polistirex and chlorpheniramine polistirex suspension, extended release United States - English - NLM (National Library of Medicine)

tuzistra xr- codeine polistirex and chlorpheniramine polistirex suspension, extended release

vernalis therapeutics, inc. - codeine phosphate anhydrous (unii: 2x585m1m3t) (codeine - unii:q830pw7520) - codeine phosphate anhydrous 14.7 mg in 5 ml - tuzistra xr is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients under 12 years of age [see contraindications (4),use in specific populations (8.4) ]. contraindicated in pediatric patients under 12 years of age [see contraindications (4),use in specific populations (8.4) ]. - contraindicated in pediatric patients 12 to 18 years of age after tonsillectomy or adenoidectomy [see contraindications (4), use in specific populations (8.4 ) ].                                                                                                                                                                                                        

HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE- hydrocodone bitartrate, chlorpheniramine mal United States - English - NLM (National Library of Medicine)

hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride- hydrocodone bitartrate, chlorpheniramine mal

paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is contraindicated for: hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate, chlorpheniramine maleate and pseudo

PAIN (chlorpheniramine maleate, methyl salicylate, scopolia carniolica whole, menthol, peppermint, camphor- synthetic, phelloden United States - English - NLM (National Library of Medicine)

pain (chlorpheniramine maleate, methyl salicylate, scopolia carniolica whole, menthol, peppermint, camphor- synthetic, phelloden

george l. rodriguez m.d., pc - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), scopolia carniolica whole (unii: xr0i456h79) (scopolia carniolica whole - unii:xr0i456h79), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), peppermint oil (unii: av092ku4jh) (peppermint - unii:v95r5kmy2b), camphor (synthetic) (unii: 5tjd82a1et) (camphor (synthetic) - unii:5tjd82a1et), phellodendron amurense whole (unii: 3ozn5ngr9l) (phellod - chlorpheniramine maleate 13.4 mg - purpose pain relief uses: for the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, muscle soreness and stiffness.

HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HCL- hydrocodone bitartrate, chlorpheniramine maleate, pse United States - English - NLM (National Library of Medicine)

hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hcl- hydrocodone bitartrate, chlorpheniramine maleate, pse

cypress pharmaceutical, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate is contraindicated for: -

DEXCHLORPHENIRAMINE MALEATE solution United States - English - NLM (National Library of Medicine)

dexchlorpheniramine maleate solution

foxland pharmaceuticals, inc. - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions: